Cite
HARVARD Citation
Kulkarni, R. et al. (n.d.). Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia. pp. 698-705. [Online].